Synapse - Works

Results (5608)

Clonal hematopoiesis in the phase 3 Alliance A031201 trial of metastatic castration resistant prostate cancer (mCRPC) treated with androgen receptor (AR)-targeted therapies

Meeting Abstract

Jensen, J. L.; Bobek, O.; Chan, I. C. C.; Hillman, D. W.; Heller, G.; Druley, T. E.; Morris, M. J.; Milowsky, M. I.; Beltran, H.; Bolton, K. L.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Building a predictive model for outcomes with [(177)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer using VISION data: Preliminary results

Meeting Abstract

Herrmann, K.; Gafita, A.; De Bono, J. S.; Sartor, A. O.; Chi, K. N.; Krause, B. J.; Rahbar, K.; Tagawa, S. T.; Czernin, J.; El-Haddad, G.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB)

Meeting Abstract

Guercio, B. J.; Ratna, N.; Gavrilov, D.; Duzgol, C.; Akhlaq, M.; Teo, M. Y.; Regazzi, A. M.; Kotecha, R. R.; Funt, S. A.; Aggen, D. H.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A single-arm, phase II study of durvalumab (D) and tremelimumab (T) for relapsed/refractory germ cell tumors (GCT)

Meeting Abstract

Funt, S. A.; Knezevic, A.; Freeman, B. A.; Bolos, M.; Martorana, V.; Donoghue, M.; Khan, S.; Singh, H.; Bromberg, M.; Quinlan, C.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Study EV-103: Neoadjuvant treatment with enfortumab vedotin monotherapy in cisplatin-ineligible patients (pts) with muscle invasive bladder cancer (MIBC): Updated results for Cohort H

Meeting Abstract

Flaig, T. W.; Rosenberg, J. E.; Hoimes, C. J.; O'Donnell, P. H.; Mar, N.; Gourdin, T. S.; Henry, S.; Bilen, M. A.; George, S.; Barata, P. C.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Mismatch repair deficiency and microsatellite instability-high in urothelial carcinoma: A systematic review and meta-analysis

Meeting Abstract

Chandran, E.; Iannantuono, G. M.; Akbulut, D.; Atiq, S. O.; Gurram, S.; Teo, M. Y.; Coleman, J.; Sinaii, N.; Apolo, A. B.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Enfortumab vedotin (EV) with or without pembrolizumab (P) in patients (pts) who are cisplatin-ineligible with previously untreated locally advanced or metastatic urothelial cancer (la/mUC): Additional 3-month follow-up on cohort K data

Meeting Abstract

Friedlander, T. W.; Milowsky, M. I.; O'Donnell, P. H.; Petrylak, D. P.; Hoimes, C. J.; Flaig, T. W.; Mar, N.; Moon, H. H.; McKay, R. R.; Bilen, M. A.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Germline mutations in hereditary renal cell carcinoma (RCC) genes among 32,240 patients with all cancer types

Meeting Abstract

Carlo, M. I.; Schroeder, A.; Mukherjee, S.; Kemel, Y.; Kotecha, R. R.; Lee, C. H.; Shah, N. J.; Feldman, D. R.; Liu, Y. L.; Walsh, M. F.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Phase 2 study of batiraxcept (AVB-S6-500, an AXL inhibitor) as monotherapy, in combination with cabozantinib (cabo), and in combination with cabo and nivolumab (nivo) in patients with advanced clear cell renal cell carcinoma (ccRCC)

Meeting Abstract

Beckermann, K.; Campbell, M. T.; Haas, N. B.; Ornstein, M. C.; Gao, X.; Mao, S. S.; Hammers, H. J.; George, S.; Nelson, A. A.; Gourdin, T. S.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Genomic determinants of progression-free survival after second line of therapy (PFS-2) for patients on immunotherapy-based combination therapies for advanced clear cell renal cell carcinoma

Meeting Abstract

Fitzgerald, K. N.; Kotecha, R. R.; Knezevic, A.; Shapnik, N.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save